Steroid use in HCV-infected liver transplant recipients
- 1 April 2009
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Gastroenterology & Hepatology
- Vol. 6 (4), 198-200
- https://doi.org/10.1038/nrgastro.2009.38
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Minimization of steroids in liver transplantationTransplant International, 2009
- Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: Results of a prospective randomized studyLiver Transplantation, 2008
- Steroid avoidance in liver transplantation: Meta-analysis and meta-regression of randomized trialsLiver Transplantation, 2008
- Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 studyLiver Transplantation, 2007
- Risk factors for hepatitis C recurrence after liver transplantationJournal of Viral Hepatitis, 2007
- Immunosuppression and outcomes of patients transplanted for hepatitis CJournal of Hepatology, 2006
- Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionJournal of Hepatology, 2006
- Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysisLiver Transplantation, 2006
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002